Viva Biotech Holdings is a prominent player in the biotechnology sector, primarily engaged in offering contract research organization (CRO) services. The company's core function is to provide integrated solutions across various stages of drug discovery and development, catering to biotech and pharmaceutical companies globally. With a comprehensive suite of services, including target validation, hit identification, lead optimization, and preclinical research, Viva Biotech plays a crucial role in advancing medical innovations. Its ability to assist in the cost-effective and efficient development of drug candidates makes it a valuable partner in the pharmaceutical pipeline. Viva Biotech Holdings impacts a range of therapeutic areas, bridging gaps between initial drug concepts and market-ready products. In the broader financial market, it holds significance as an enabler of healthcare breakthroughs and a contributor to the dynamic field of life sciences, supporting the creation of new therapies and treatments. Headquartered in Shanghai, Viva Biotech's strategic positioning facilitates strong collaborations with leading global biotech firms, reinforcing its role as a dynamic force within the biotech industry's service sector.